RxDoctor Payments DataLook up a doctor →

Rhonda Morse, NP

Family · Burton, MINPI 1154778132

Payments from drug & device makers

$16,953in general payments, 2019–2025

Across 1,105 payments — averaging $15.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Amgen$1K
  • AstraZeneca$1K
  • Harmony Biosciences LLC$1K
  • Novo Nordisk$864
  • Lilly USA, LLC$783
  • plus $10K from 54 others

What the payments were for

  • Food & beverage$16,77799%
  • Education$1761%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie203$1,803
Amgen(2 entities)98$1,307
AstraZeneca(2 entities)40$1,246
Harmony Biosciences LLC54$1,035
Novo Nordisk57$864
Lilly USA, LLC68$783
Corcept Therapeutics36$704
Pfizer43$634
Teva Pharmaceuticals USA, Inc.36$617
Boehringer Ingelheim30$581
Lundbeck LLC39$558
Otsuka America Pharmaceutical, Inc.27$469
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC28$433
Ironwood Pharmaceuticals, Inc14$322
Novartis19$303
Biohaven Pharmaceuticals, Inc.8$298
Bayer20$288
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)20$276
Collegium Pharmaceutical, Inc.15$259
Vanda Pharmaceuticals Inc.17$247
Takeda Pharmaceuticals U.S.A., Inc.13$242
Paratek Pharmaceuticals, Inc.23$227
Astellas Pharma US Inc14$226
GSK10$222
Exact Sciences10$221
Axsome Therapeutics, Inc.11$208
Neurocrine Biosciences, Inc.13$193
Merck14$183
Radius Health, Inc.7$163
Johnson & Johnson9$162
Alkermes, Inc.9$158
Nestle Healthcare Nutrition Inc.9$141
Abbott7$128
Xeris Pharmaceuticals, Inc.6$113
Ironshore Pharmaceuticals Inc.6$109
Scilex Pharmaceuticals Inc.5$99
Idorsia Pharmaceuticals US Inc5$89
Sunovion Pharmaceuticals Inc.4$85
Aimmune Therapeutics, Inc.4$83
Eisai Inc.4$75
Sanofi-aventis U.S. LLC4$69
Jazz Pharmaceuticals Inc.3$65
Phathom Pharmaceuticals, Inc.4$64
Dexcom, Inc.3$53
Biohaven Pharmaceutical Holding Company Ltd.2$45
Mylan Specialty L.p.2$40
Indivior Inc.2$39
Insulet Corporation2$35
Orexo US, Inc.2$32
Braeburn Inc.2$31
Verona Pharma, Inc.2$29
Medtronic2$25
Clarus Therapeutics Inc.1$22
Sanofi Pasteur Inc.1$20
Supernus Pharmaceuticals, Inc.1$18
Vivus LLC1$18
Smith+Nephew1$17
Athena Bioscience, LLC1$17
Adlon Therapeutics L.p.1$16
Shield Therapeutics Inc1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,953 in reported general payments places this provider in the 95th percentile of 3,657 family providers in Michigan.

See all family providers in Michigan

Medicare billing

Part B allowed, 2024
$24,011
Medicare patients
117
Services billed
314

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide57$64,977
OzempicSemaglutide25$36,846
TrulicityDulaglutide23$32,361
Trelegy ElliptaFluticasone/Umeclidin/Vilanter34$30,160
RexultiBrexpiprazole17$22,633
FarxigaDapagliflozin Propanediol33$21,614
Lurasidone Hcl16$21,316
EliquisApixaban11$19,289
Breztri AerosphereBudesonide/Glycopyr/Formoterol25$17,744
XareltoRivaroxaban11$16,080
JardianceEmpagliflozin16$14,523
Nurtec OdtRimegepant Sulfate13$14,310
EntrestoSacubitril/Valsartan13$13,682
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen618$12,370
MyrbetriqMirabegron13$11,829

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$783$97,33880 claims
AstraZenecaFarxiga, Breztri Aerosphere$1,246$39,35858 claims
Novo NordiskOzempic$864$36,84625 claims
PfizerEliquis, Nurtec Odt$634$33,59824 claims
GSKTrelegy Ellipta$222$30,16034 claims
Otsuka America Pharmaceutical, Inc.Rexulti$469$22,63317 claims
Boehringer IngelheimJardiance, Spiriva Respimat$581$20,07927 claims
Johnson & JohnsonXarelto$162$16,08011 claims
NovartisEntresto$303$13,68213 claims
Astellas Pharma US IncMyrbetriq$226$11,82913 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,657 family providers in Michigan.

Other family in Burton

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →